Variational AI is a company that specializes in drug discovery using state-of-the-art generative AI. The company was founded in September 2019 and is composed of experienced AI/machine learning and business specialists. They work closely with biopharmaceutical partners to bring new therapeutics to market across disease areas and positively impact lives.

Variational AI uses state-of-the-art machine learning in a data-efficient method to rapidly generate novel and diverse compounds that are optimized for multiple properties to avoid the most common causes of drug attrition and increase clinical probability of success.

‍

Variational AI
AI/ML
Healthcare
Founded
2019
Partnered
September 2019
IPO
Acquired